DDX17 and metabolic dysfunction-associated steatohepatitis: These results suggested that Cyp2c29 and its metabolites 14,15‐EET might mediate the function of DDX17 in lipid accumulation in hepatocytes and macrophage activation in order to promotes the NASH progression.